AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0140
-0.0008 (-5.41%)
Jul 2, 2024, 3:38 PM EDT - Market closed

AXIM Biotechnologies Statistics

Total Valuation

AXIM has a market cap or net worth of $4.08 million. The enterprise value is $10.35 million.

Market Cap 4.08M
Enterprise Value 10.35M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

AXIM has 291.46 million shares outstanding. The number of shares has increased by 21.87% in one year.

Shares Outstanding 291.46M
Shares Change (YoY) +21.87%
Shares Change (QoQ) +8.84%
Owned by Insiders (%) 25.58%
Owned by Institutions (%) n/a
Float 217.66M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 47.81
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 121.32
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio 0.02
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.71

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -141.35%
Return on Capital (ROIC) n/a
Revenue Per Employee $14,225
Profits Per Employee -$931,559
Employee Count 6
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

In the past 12 months, AXIM has paid $503,105 in taxes.

Income Tax 503,105
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -57.06% in the last 52 weeks. The beta is 1.10, so AXIM's price volatility has been higher than the market average.

Beta (5Y) 1.10
52-Week Price Change -57.06%
50-Day Moving Average 0.01
200-Day Moving Average 0.02
Relative Strength Index (RSI) 67.42
Average Volume (20 Days) 297,312

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, AXIM had revenue of $85,348 and -$5.59 million in losses. Loss per share was -$0.02.

Revenue 85,348
Gross Profit -342,924
Operating Income -2.44M
Pretax Income -5.59M
Net Income -5.59M
EBITDA -2.02M
EBIT -2.44M
Loss Per Share -$0.02
Full Income Statement

Balance Sheet

The company has $96,711 in cash and $6.37 million in debt, giving a net cash position of -$6.27 million or -$0.02 per share.

Cash & Cash Equivalents 96,711
Total Debt 6.37M
Net Cash -6.27M
Net Cash Per Share -$0.02
Equity (Book Value) -7.43M
Book Value Per Share -0.03
Working Capital -4.71M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.96 million and capital expenditures -$2,839, giving a free cash flow of -$1.96 million.

Operating Cash Flow -1.96M
Capital Expenditures -2,839
Free Cash Flow -1.96M
FCF Per Share -$0.01
Full Cash Flow Statement

Margins

Gross margin is -401.80%, with operating and profit margins of -2,864.23% and -6,548.90%.

Gross Margin -401.80%
Operating Margin -2,864.23%
Pretax Margin -6,548.90%
Profit Margin -6,548.90%
EBITDA Margin -2,362.43%
EBIT Margin -2,864.22%
FCF Margin -2,294.65%

Dividends & Yields

AXIM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -21.87%
Shareholder Yield -21.87%
Earnings Yield -136.98%
FCF Yield -48.00%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AXIM has an Altman Z-Score of -28.89 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -28.89
Piotroski F-Score 4